Versant Capital Management, Inc Novavax Inc Transaction History

Versant Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$69.73 - $142.9 $139 - $285	-2 Closed	0 $0
Q4 2021 Jan 06, 2022	SELL	$134.56 - $217.97 $672 - $1,089	-5 Reduced 71.43%	2 $0
Q3 2021 Oct 29, 2021	BUY	$177.8 - $270.58 $355 - $541	2 Added 40.0%	7 $1,000
Q2 2021 Jul 22, 2021	BUY	$121.0 - $257.67 $242 - $515	2 Added 66.67%	5 $1,000
Q1 2021 Apr 27, 2021	BUY	$112.98 - $319.93 $338 - $959	3 New	3 $1,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.